yield10.png
Yield10 Bioscience CEO Dr. Oliver Peoples to Present at BIO 2017
20 juin 2017 09h00 HE | Yield10 Bioscience, Inc.
WOBURN, Mass., June 20, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced that CEO Oliver Peoples, Ph.D., will be presenting today at BIO 2017 on a panel entitled:...
yield10.png
Yield10 Bioscience Submits “Am I Regulated?” Letter to USDA-APHIS BRS for Genome-Edited Camelina
15 juin 2017 08h45 HE | Yield10 Bioscience, Inc.
WOBURN, Mass., June 15, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that it has submitted an “Am I Regulated?” letter to USDA-APHIS’s Biotechnology Regulatory...
yield10.png
Yield10 Bioscience to Present at the Marcum Microcap Investor Conference
14 juin 2017 09h00 HE | Yield10 Bioscience, Inc.
WOBURN, Mass., June 14, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that Oliver Peoples, Ph.D., President and Chief Executive Officer, will present at the Marcum...
yield10.png
Yield10 Bioscience Regains Compliance with NASDAQ Minimum Bid Price Listing Requirement
13 juin 2017 10h45 HE | Yield10 Bioscience, Inc.
WOBURN, Mass., June 13, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that it has received a letter from The NASDAQ Stock Market LLC notifying the Company that it...
yield10.png
Yield10 Bioscience Starts Field Tests of Novel Yield Trait Gene C3003 in Oilseed Crops Camelina and Canola
07 juin 2017 09h00 HE | Yield10 Bioscience, Inc.
WOBURN, Mass., June 07, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) today announced that planting has been completed at study sites in Canada for field tests to evaluate the...
yield10.png
Yield10 Bioscience Announces 1-for-10 Reverse Stock Split
26 mai 2017 08h30 HE | Yield10 Bioscience, Inc.
WOBURN, Mass., May 26, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that it will effect a 1-for-10 reverse stock split of its common stock, following stockholder...
yield10.png
Yield10 Bioscience Announces First Quarter 2017 Financial Results
11 mai 2017 16h05 HE | Yield10 Bioscience, Inc.
WOBURN, Mass., May 11, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) today reported financial results for the three months ended March 31, 2017.Yield10 Bioscience kicked off the...
yield10.png
Yield10 Bioscience to Host Webcast of its First Quarter 2017 Conference Call
26 avr. 2017 09h01 HE | Yield10 Bioscience, Inc.
WOBURN, Mass., April 26, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that the Company plans to release its first quarter 2017 financial results and host a...
yield10.png
Yield10 Bioscience Outlines Plans for Spring 2017 Field Tests of Novel Yield Trait Gene C3003 in Camelina and Canola
13 mars 2017 09h00 HE | Yield10 Bioscience, Inc.
WOBURN, Mass., March 13, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) today outlined plans for its Spring 2017 field tests of the novel yield trait gene C3003 in Camelina and...
yield10.png
Yield10 Bioscience Reports Promising Greenhouse Results for Second Generation C3003 Trait in Camelina
09 mars 2017 09h00 HE | Yield10 Bioscience, Inc.
WOBURN, Mass., March 09, 2017 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) today announced greenhouse results in its model Camelina system showing that its second generation novel...